OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1)Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoformsAdenoviral transduction of enterocytes and M-cells using in vitro models based on Caco-2 cells: the coxsackievirus and adenovirus receptor (CAR) mediates both apical and basolateral transductionUse of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomesMolecular imaging of intracellular drug-membrane aggregate formationFunctional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug deliveryApical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug targetA molecular link between the active component of marijuana and Alzheimer's disease pathologyExploiting dendrimer multivalency to combat emerging and re-emerging infectious diseasesMicelle-like nanoparticles as carriers for DNA and siRNADeep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataProtonation and Trapping of a Small pH-Sensitive Near-Infrared Fluorescent Molecule in the Acidic Tumor Environment Delineate Diverse Tumors in Vivo.Multiscale Framework for Imaging Radiolabeled TherapeuticsPhagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA SecretionPhysiological parameters for oral delivery and in vitro testingDirected antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responsesDesign, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agentsProlidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugsTherapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imigluceraseBioavailability of curcumin: problems and promisesComparison of human and monkey peptide transporters: PEPT1 and PEPT2Tumor ablation and nanotechnology.Nanotechnologies for noninvasive measurement of drug releaseMultilayered polymer-coated carbon nanotubes to deliver dasatinib.Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretionADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockageTransport of organic cations across the blood-testis barrierChemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer CellsAdsorption of Drugs on Nanodiamond: Toward Development of a Drug Delivery PlatformMechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerThe Absence of CpG in Plasmid DNA–Chitosan Polyplexes Enhances Transfection Efficiencies and Reduces Inflammatory Responses in Murine LungsTargeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells.The intracellular pharmacokinetics of terminally capped peptides.Direct NMR monitoring of phase separation behavior of highly supersaturated nifedipine solution stabilized with hypromellose derivatives.Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics.Selective downregulation of the MDR1 gene product in Caco-2 cells by stable transfection to prove its relevance in secretory drug transport.Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.Photolytic Cross-Linking to Probe Protein-Protein and Protein-Matrix Interactions in Lyophilized PowdersFormulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
P1433
Q24295154-E77F9A45-D687-4817-9FD8-5E19EFD22335Q24301940-7D4E19F0-B623-4502-AF68-0C90985AD234Q24303580-7E537FE9-0D18-416F-A37C-40EC6D0CD75FQ24605911-9D25C6D4-A315-4E45-98A8-6373BD8185B5Q24635290-266F81E3-AE09-4015-8500-07D7E25BE3EDQ24644494-07617E73-CC53-4D14-B904-2B13F5AFDDD5Q24655792-AF4234F3-BF01-41F7-AAA0-B1ACBE09B427Q24657485-CFC7A44F-76D0-45CC-9628-EF800E80EFECQ26852693-8EB0A53A-161F-4F68-8FFA-3DA3070A67B5Q27001558-4C6D2B91-8993-462D-BFFE-89451E6A236BQ27301054-646FBBBC-B6CA-43F1-BA5D-9CAC5BDB950BQ27301068-FC3E9A51-9FB9-48E4-B08D-F9481AC5B9C7Q27301080-D1E1A911-1001-43EB-BBEF-DC7363EC7DF7Q27301088-8825E7CB-C00A-4FBF-A55A-C02A2BE66162Q27687044-1D3D6786-172E-4233-81F2-AEE529633AA3Q28211852-B4112A7B-E218-4049-AE48-FF0E5EF91321Q28241000-FB981A2F-193C-4B77-94CA-74D90FEC5BE1Q28242977-671FD8DF-2D82-4DCC-A878-2258DD3F9D38Q28250172-29A76323-3932-48AF-ACE9-B85DEDDA0EC1Q28257125-B7636B85-1706-4802-BD49-90C0CEEC6BAFQ28258540-61E77F2B-C5E3-4DD6-9D54-ECFEB1998642Q28385067-D7BF18BD-AE23-4D74-B478-CBDD16458C07Q28387499-64C1B5AC-CA60-45D5-95E5-2B1F9EBF3BD1Q28388350-AEF89754-64FA-4426-9AC0-B4017FDE097BQ28570070-8F863A6A-A5A3-48E8-856F-2F5EECE9EF95Q28730653-364A2839-CFAB-4DC9-B716-D50016C67233Q28771346-0B462C69-0BD7-4A4D-A568-17AF2F001BA9Q28816971-23E75588-C232-489E-931C-FD05B0BFA14CQ29031132-3F15B2CA-6264-422D-A04E-295F15DAE8DAQ29247912-02FBF005-3A39-453D-A608-280F81050159Q29248502-92C869C7-3E3E-4C00-AE97-6EF28CBEBFF2Q30008796-58817F28-28E6-4ED5-82BE-2D92710B1CC0Q30010141-8B72DC36-7726-4839-BFB9-C8FFFEAABD73Q30101110-D771A887-19A8-4AC8-B921-88F90A2391AEQ30319016-D3D84CAE-0E59-42E6-A623-72E0979F2D34Q30320255-A1ACFE7D-DF29-4588-8A6C-767327C3FB9BQ30359568-3C337D0E-1863-425E-80A3-B83375D5ADD4Q30359572-2A29B049-202B-4ADC-A9A2-3931801A6426Q30377081-A9B358E4-3B34-4AF7-8C71-915B370358E3Q30385768-1CBF4E05-BFDF-4BD3-BB5C-585867A8E6DD
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van American Chemical Society
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Molecular Pharmaceutics
@ast
Molecular Pharmaceutics
@ca
Molecular Pharmaceutics
@da
Molecular Pharmaceutics
@de
Molecular Pharmaceutics
@en
Molecular Pharmaceutics
@es
Molecular Pharmaceutics
@fi
Molecular Pharmaceutics
@fr
Molecular Pharmaceutics
@it
Molecular Pharmaceutics
@nb
type
label
Molecular Pharmaceutics
@ast
Molecular Pharmaceutics
@ca
Molecular Pharmaceutics
@da
Molecular Pharmaceutics
@de
Molecular Pharmaceutics
@en
Molecular Pharmaceutics
@es
Molecular Pharmaceutics
@fi
Molecular Pharmaceutics
@fr
Molecular Pharmaceutics
@it
Molecular Pharmaceutics
@nb
altLabel
Mol. Pharm.
@it
prefLabel
Molecular Pharmaceutics
@ast
Molecular Pharmaceutics
@ca
Molecular Pharmaceutics
@da
Molecular Pharmaceutics
@de
Molecular Pharmaceutics
@en
Molecular Pharmaceutics
@es
Molecular Pharmaceutics
@fi
Molecular Pharmaceutics
@fr
Molecular Pharmaceutics
@it
Molecular Pharmaceutics
@nb
P243
P3181
P4616
P101
P1055
P1058
P1144
2003212143
P1156
P1159
P1160
Mol. Pharm.
P1250
P1277
P1476
Molecular Pharmaceutics
@en